A Trial of SHR-A1904 in Patients With Advanced Pancreatic Cancer
Clinical trial NCT04928625 · UNKNOWN
Trial details
- NCT number
- NCT04928625
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-06
- Primary completion
- 2023-06-30
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.